Seven Bridges to provide scRNAseq data management for Pfizer

By The Science Advisory Board staff writers

February 24, 2021 -- Bioinformatics provider Seven Bridges has been selected by Pfizer to provide data management services for Pfizer's single-cell RNA sequencing (scRNAseq) data.

The Seven Bridges platform is a cloud-based environment for conducting bioinformatic analyses where teams can store, analyze, and interpret data.

Under the agreement, Seven Bridges will support Pfizer by centralizing and managing terabytes of raw and processed scRNAseq data. These data provide detailed analysis of gene expression in individual cells. But the totality of scRNAseq data can carry a very large footprint. The Seven Bridges platform will provide a cost-effective, secure, end-to-end, scalable, durable, and reliable data storage and management solution for Pfizer.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.